These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 30982973)
1. Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway. Pal M J Cell Physiol; 2019 Nov; 234(11):20266-20274. PubMed ID: 30982973 [TBL] [Abstract][Full Text] [Related]
2. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor. Steffan JJ; Koul HK Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212 [TBL] [Abstract][Full Text] [Related]
3. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Gu X; Zerbini LF; Otu HH; Bhasin M; Yang Q; Joseph MG; Grall F; Onatunde T; Correa RG; Libermann TA Cancer Res; 2007 May; 67(9):4219-26. PubMed ID: 17483333 [TBL] [Abstract][Full Text] [Related]
4. Signatures of prostate-derived Ets factor (PDEF) in cancer. Mahajan N Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells. Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100 [TBL] [Abstract][Full Text] [Related]
6. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells. Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555 [TBL] [Abstract][Full Text] [Related]
8. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF. Johnson TR; Koul S; Kumar B; Khandrika L; Venezia S; Maroni PD; Meacham RB; Koul HK Mol Cancer; 2010 Jun; 9():148. PubMed ID: 20550708 [TBL] [Abstract][Full Text] [Related]
9. HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion. Kim IJ; Kang TW; Jeong T; Kim YR; Jung C Int J Oncol; 2014 Aug; 45(2):869-76. PubMed ID: 24898171 [TBL] [Abstract][Full Text] [Related]
10. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. Turner DP; Moussa O; Sauane M; Fisher PB; Watson DK Cancer Res; 2007 Feb; 67(4):1618-25. PubMed ID: 17308102 [TBL] [Abstract][Full Text] [Related]
13. PDEF downregulates stathmin expression in prostate cancer. Sabherwal Y; Mahajan N; Helseth DL; Gassmann M; Shi H; Zhang M Int J Oncol; 2012 Jun; 40(6):1889-99. PubMed ID: 22378487 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. Turner DP; Findlay VJ; Moussa O; Semenchenko VI; Watson PM; LaRue AC; Desouki MM; Fraig M; Watson DK Prostate; 2011 Dec; 71(16):1723-35. PubMed ID: 21446014 [TBL] [Abstract][Full Text] [Related]
15. The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells. Chen X; Corbin JM; Tipton GJ; Yang LV; Asch AS; Ruiz-Echevarría MJ Biochim Biophys Acta; 2014 Jun; 1843(6):1216-24. PubMed ID: 24632071 [TBL] [Abstract][Full Text] [Related]
16. Loss of P53 facilitates invasion and metastasis of prostate cancer cells. Wang Y; Zhang YX; Kong CZ; Zhang Z; Zhu YY Mol Cell Biochem; 2013 Dec; 384(1-2):121-7. PubMed ID: 23982184 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma. Sun F; Wang J; Sun Q; Li F; Gao H; Xu L; Zhang J; Sun X; Tian Y; Zhao Q; Shen H; Zhang K; Liu J J Exp Clin Cancer Res; 2019 Nov; 38(1):449. PubMed ID: 31684995 [TBL] [Abstract][Full Text] [Related]
18. Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma. Yang SH; Lin HY; Changou CA; Chen CH; Liu YR; Wang J; Jiang X; Luh F; Yen Y Oncotarget; 2016 Jan; 7(1):362-73. PubMed ID: 26517522 [TBL] [Abstract][Full Text] [Related]
19. H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. Bacci L; Aiello A; Ripoli C; Loria R; Pugliese D; Pierconti F; Rotili D; Strigari L; Pinto F; Bassi PF; Mai A; Grassi C; Pontecorvi A; Falcioni R; Farsetti A; Nanni S Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426484 [TBL] [Abstract][Full Text] [Related]
20. CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling. Chi Y; Huang S; Wang L; Zhou R; Wang L; Xiao X; Li D; Cai Y; Zhou X; Wu J BMC Cancer; 2014 Aug; 14():577. PubMed ID: 25106495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]